-
公开(公告)号:US20170143852A1
公开(公告)日:2017-05-25
申请号:US15369701
申请日:2016-12-05
Inventor: Jinming GAO , Gang HUANG , Tian ZHAO , Xinpeng MA , Yiguang WANG , Yang LI , Baran D. SUMER
IPC: A61K49/00 , G01N33/58 , C08F8/30 , G01N21/64 , C08F8/32 , C08F8/34 , C09B69/10 , G01N33/84 , C08F8/42
CPC classification number: A61K49/0054 , A61K49/0021 , A61K49/0032 , A61K49/0041 , C08F8/30 , C08F8/32 , C08F8/34 , C08F8/42 , C09B69/103 , C09B69/105 , C09B69/106 , C09B69/109 , G01N21/6428 , G01N21/643 , G01N21/6456 , G01N33/582 , G01N33/84 , G01N2021/6432 , G01N2021/6439 , G01N2021/6441
Abstract: The present disclosure relates to polymers which contain a hydrophobic and hydrophilic segment which is sensitive to pH. In some aspects, the polymers form a micelle which is sensitive to pH and results in a change in fluorescence based upon the particular pH. In some aspects, the disclosure also provides methods of using the polymers for the imaging of cellular or extracellular environment or delivering a drug.
-
公开(公告)号:US20210338840A1
公开(公告)日:2021-11-04
申请号:US17231922
申请日:2021-04-15
Inventor: Jinming GAO , Gang HUANG , Tian ZHAO , Xinpeng MA , Yiguang WANG , Yang LI , Baran D. SUMER
IPC: A61K49/00 , G01N21/64 , C08F8/30 , C08F8/32 , C08F8/34 , C08F8/42 , C09B69/10 , G01N33/58 , G01N33/84
Abstract: The present disclosure relates to polymers which contain a hydrophobic and hydrophilic segment which is sensitive to pH. In some aspects, the polymers form a micelle which is sensitive to pH and results in a change in fluorescence based upon the particular pH. In some aspects, the disclosure also provides methods of using the polymers for the imaging of cellular or extracellular environment or delivering a drug.
-
公开(公告)号:US20240115741A1
公开(公告)日:2024-04-11
申请号:US18449675
申请日:2023-08-14
Inventor: Jinming GAO , Gang HUANG , Tian ZHAO , Xinpeng MA , Yiguang WANG , Yang LI , Baran D. SUMER
IPC: A61K49/00 , C08F8/30 , C08F8/32 , C08F8/34 , C08F8/42 , C09B69/10 , G01N21/64 , G01N33/58 , G01N33/84
CPC classification number: A61K49/0054 , A61K49/0021 , A61K49/0032 , A61K49/0041 , C08F8/30 , C08F8/32 , C08F8/34 , C08F8/42 , C09B69/103 , C09B69/105 , C09B69/106 , C09B69/109 , G01N21/6428 , G01N21/643 , G01N21/6456 , G01N33/582 , G01N33/84 , G01N2021/6432 , G01N2021/6439 , G01N2021/6441
Abstract: The present disclosure relates to polymers which contain a hydrophobic and hydrophilic segment which is sensitive to pH. In some aspects, the polymers form a micelle which is sensitive to pH and results in a change in fluorescence based upon the particular pH. In some aspects, the disclosure also provides methods of using the polymers for the imaging of cellular or extracellular environment or delivering a drug.
-
公开(公告)号:US20180369424A1
公开(公告)日:2018-12-27
申请号:US16114187
申请日:2018-08-27
Inventor: Jinming GAO , Gang HUANG , Tian ZHAO , Xinpeng MA , Yiguang WANG , Yang LI , Baran D. SUMER
IPC: A61K49/00 , C09B69/10 , G01N33/84 , G01N33/58 , G01N21/64 , C08F8/42 , C08F8/34 , C08F8/32 , C08F8/30
Abstract: The present disclosure relates to polymers which contain a hydrophobic and hydrophilic segment which is sensitive to pH. In some aspects, the polymers form a micelle which is sensitive to pH and results in a change in fluorescence based upon the particular pH. In some aspects, the disclosure also provides methods of using the polymers for the imaging of cellular or extracellular environment or delivering a drug.
-
公开(公告)号:US20180099002A1
公开(公告)日:2018-04-12
申请号:US15834052
申请日:2017-12-06
Applicant: The Board of Regents of the University of Texas System , The Board of Trustees of the University of Illinois
Inventor: Paul J. HERGENROTHER , David A. BOOTHMAN , Joseph S. BAIR , Lifen CAO , Jinming GAO , Xiumei HUANG , Xiuquan LUO , Xinpeng MA , Zachary R. MOORE , Elizabeth I. PARKINSON
IPC: A61K31/706 , A61K31/4745 , A61K31/4738 , A61K31/131 , A61K45/06 , C12Q1/6886 , A61K31/353
Abstract: The therapies described herein can be selectively lethal toward a variety of different cancer cell types and cancer conditions in a subject. The combination therapies described herein can be useful for the management, treatment, control, or adjunct treatment of diseases, where the selective legality is beneficial in chemotherapeutic therapy, particularly where the disease is accompanied by elevated levels of NQO1.
-
公开(公告)号:US20190071380A1
公开(公告)日:2019-03-07
申请号:US16063347
申请日:2016-12-16
Inventor: Jinming GAO , Yuliang LIU , Qi WEI , Xinpeng MA , Gang HUANG
IPC: C07C50/32 , C07C311/21 , C07C233/33 , C07C225/30 , C07D295/116 , C07C233/42 , C07C233/91 , C07C311/08 , A61P35/00
CPC classification number: C07C50/32 , A61K9/0019 , A61K9/5123 , A61K9/5146 , A61P35/00 , C07C205/46 , C07C225/30 , C07C233/18 , C07C233/31 , C07C233/33 , C07C233/42 , C07C233/91 , C07C271/30 , C07C311/08 , C07C311/09 , C07C311/21 , C07C311/51 , C07C2601/14 , C07C2602/10 , C07D295/116 , C07D317/70
Abstract: Provided herein are naphthoquinones compounds such as those with a hydrogen bond donating group of the formula (I): wherein: R1, R2, R3, R4, R5, and n are as defined herein. Also provided herein are pharmaceutical composition of the present compounds and methods of treatment using the compounds including their use in the treatment of cancer.
-
公开(公告)号:US20160030457A1
公开(公告)日:2016-02-04
申请号:US14783344
申请日:2014-04-08
Applicant: THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS , THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
Inventor: Paul J. HERGENROTHER , David A. BOOTHMAN , Joseph S. BAIR , Lifen CAO , Jinming GAO , Xiumei HUANG , Xiuquan LUO , Xinpeng MA , Zachary R. MOORE , Elizabeth I. PARKINSON
IPC: A61K31/706 , A61K31/4745 , A61K45/06 , A61K31/353 , A61K31/131
CPC classification number: A61K31/706 , A61K31/131 , A61K31/353 , A61K31/4738 , A61K31/4745 , A61K45/06 , C12Q1/6886 , C12Q2600/106 , C12Q2600/158 , A61K2300/00
Abstract: The therapies described herein can be selectively lethal toward a variety of different cancer cell types and cancer conditions in a subject. The combination therapies described herein can be useful for the management, treatment, control, or adjunct treatment of diseases, where the selective lethality is beneficial in chemotherapeutic therapy, particularly where the disease is accompanied by elevated levels of NQO1.
Abstract translation: 本文所述的疗法可以选择性地对受试者中各种不同的癌细胞类型和癌症状况致命。 本文所述的联合治疗可用于治疗,治疗,控制或辅助治疗疾病,其中选择性致死性在化学治疗中是有益的,特别是在疾病伴随着NQO1水平升高的情况下。
-
-
-
-
-
-